[HTML][HTML] Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced …
SE Bove, SL Calcaterra, RM Brooker, CM Huber… - Osteoarthritis and …, 2003 - Elsevier
Objective: To describe an in vivo model in the rat in which change in weight distribution is
used as a measure of disease progression and efficacy of acetaminophen and two …
used as a measure of disease progression and efficacy of acetaminophen and two …
[引用][C] Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced …
B SE - Osteoarthritis Cartilage, 2003 - cir.nii.ac.jp
Weight bearing as a measure of disease progression and efficacy of anti-inflammatory
compounds in a model of monosodium iodoacetate-induced osteoarthritis | CiNii Research …
compounds in a model of monosodium iodoacetate-induced osteoarthritis | CiNii Research …
Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis
SE Bove, SL Calcaterra, RM Brooker… - Osteoarthritis and …, 2003 - pubmed.ncbi.nlm.nih.gov
Objective To describe an in vivo model in the rat in which change in weight distribution is
used as a measure of disease progression and efficacy of acetaminophen and two …
used as a measure of disease progression and efficacy of acetaminophen and two …
[PDF][PDF] Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced …
SE Bove, SL Calcaterra, RM Brooker… - OsteoArthritis and …, 2003 - academia.edu
Objective: To describe an in vivo model in the rat in which change in weight distribution is
used as a measure of disease progression and efficacy of acetaminophen and two …
used as a measure of disease progression and efficacy of acetaminophen and two …
[PDF][PDF] Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced …
SE Bove, SL Calcaterra, RM Brooker… - OsteoArthritis and …, 2003 - core.ac.uk
Objective: To describe an in vivo model in the rat in which change in weight distribution is
used as a measure of disease progression and efficacy of acetaminophen and two …
used as a measure of disease progression and efficacy of acetaminophen and two …
Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis.
SE Bove, SL Calcaterra, RM Brooker… - Osteoarthritis and …, 2003 - europepmc.org
Objective To describe an in vivo model in the rat in which change in weight distribution is
used as a measure of disease progression and efficacy of acetaminophen and two …
used as a measure of disease progression and efficacy of acetaminophen and two …
Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis
SE Bove, SL Calcaterra, RM Brooker, CM Huber… - Osteoarthritis and …, 2003 - infona.pl
Objective: To describe an in vivo model in the rat in which change in weight distribution is
used as a measure of disease progression and efficacy of acetaminophen and two …
used as a measure of disease progression and efficacy of acetaminophen and two …
Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis
SE Bove, SL Calcaterra, RM Brooker… - Osteoarthritis and …, 2003 - oarsijournal.com
Objective: To describe an in vivo model in the rat in which change in weight distribution is
used as a measure of disease progression and efficacy of acetaminophen and two …
used as a measure of disease progression and efficacy of acetaminophen and two …
Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis
SE Bove, SL Calcaterra, RM Brooker, CM Huber… - Osteoarthritis and …, 2003 - infona.pl
Objective: To describe an in vivo model in the rat in which change in weight distribution is
used as a measure of disease progression and efficacy of acetaminophen and two …
used as a measure of disease progression and efficacy of acetaminophen and two …
[PDF][PDF] Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced …
SE Bove, SL Calcaterra, RM Brooker… - OsteoArthritis and …, 2003 - academia.edu
Objective: To describe an in vivo model in the rat in which change in weight distribution is
used as a measure of disease progression and efficacy of acetaminophen and two …
used as a measure of disease progression and efficacy of acetaminophen and two …